Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature

Can We Improve Quality of Life of Patients on Dialysis?

(2013) B. G. Jaar et al.   Clinical Journal of the American Society of Nephrology

Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura

(2012) James N. George   AMERICAN JOURNAL OF HEMATOLOGY

Evaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus

(2012) C. Barber et al.   Clinical Journal of the American Society of Nephrology

Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

(2012) A. S. Bomback et al.   Clinical Journal of the American Society of Nephrology

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

(2012) Aude Servais et al.   KIDNEY INTERNATIONAL

The Perpetual Challenge of Infectious Diseases

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

(2012) Seetha Radhakrishnan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case

(2012) Elisa Gnappi et al.   PEDIATRIC NEPHROLOGY

Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study

(2011) Paolo Cravedi et al.   AMERICAN JOURNAL OF NEPHROLOGY

Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement

(2011) S. Sethi et al.   Clinical Journal of the American Society of Nephrology

Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial

(2011) P. Ravani et al.   Clinical Journal of the American Society of Nephrology

Complement and glomerular disease: new insights

(2011) Matthew Pickering et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Recovery of Renal Function in a Dialysis-dependent Patient with Microscopic Polyangiitis and both Myeloperoxidase Anti-neutrophil Cytoplasmic Antibodies and Anti-glomerular Basement Membrane Antibodies

(2011) Shintaro Mandai et al.   INTERNAL MEDICINE

Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis

(2011) M. Morigi et al.   JOURNAL OF IMMUNOLOGY

A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy

(2011) K. El Karoui et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis

(2011) Damien Brackman et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility

(2011) Jian Zhao et al.   PLoS Genetics

The Role of Endothelial Cell Injury in Thrombotic Microangiopathy

(2010) Ryan J. Goldberg et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies

(2010) Hitoshi Watanabe et al.   Clinical and Experimental Nephrology

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

(2010) M. Noris et al.   Clinical Journal of the American Society of Nephrology

Successful Treatment with Rituximab in a Patient with TTP Secondary to Severe ANCA-Associated Vasculitis

(2010) Yukari Asamiya et al.   INTERNAL MEDICINE

Registry of 919 Patients with Thrombotic Microangiopathies across Japan: Database of Nara Medical University during 1998-2008

(2010) Yoshihiro Fujimura et al.   INTERNAL MEDICINE

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

(2010) Rubén Martínez-Barricarte et al.   JOURNAL OF CLINICAL INVESTIGATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

New Treatment Options for Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab

(2010) Özlem Köse et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Intrapulmonary Hemorrhage in Collagen-Vascular Diseases Includes a Spectrum of Underlying Conditions

(2009) Shoko Kobayashi et al.   INTERNAL MEDICINE

Clinicopathological Characteristics and Outcome of Chinese Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: A 9-Year Retrospective Study

(2009) Wen Zhang et al.   NEPHRON CLINICAL PRACTICE

Atypical Hemolytic–Uremic Syndrome

(2009) Marina Noris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab

(2008) Megha Suri et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Successful treatment of thrombotic thrombocytopenic purpura with repeated plasma exchange in a patient with microscopic polyangitis

(2008) Koji Nagai et al.   Modern Rheumatology

Properdin: New roles in pattern recognition and target clearance

(2008) Claudia Kemper et al.   MOLECULAR IMMUNOLOGY

Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria

(2008) S. A. De Serres et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008)   NEW ENGLAND JOURNAL OF MEDICINE